<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2954-4122</journal-id>
<journal-title><![CDATA[Archivos de neurociencias (México)]]></journal-title>
<abbrev-journal-title><![CDATA[Arch. Neurocien. (Mex.)]]></abbrev-journal-title>
<issn>2954-4122</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez"]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2954-41222024000300097</article-id>
<article-id pub-id-type="doi">10.24875/anc.m24000006</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Uso de dexametasona en pacientes con hematoma subdural crónico: una revisión sistemática]]></article-title>
<article-title xml:lang="en"><![CDATA[Use of dexamethasone in patients with chronic subdural hematoma: a systematic review]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alcaraz-López]]></surname>
<given-names><![CDATA[Daniela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ayala-Obeso]]></surname>
<given-names><![CDATA[Alondra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Reyes-Pérez]]></surname>
<given-names><![CDATA[Narce D.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Autónoma de Sinaloa Extensión Los Mochis Facultad de Medicina]]></institution>
<addr-line><![CDATA[Culiacán ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Guadalajara Centro Universitario de Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Guadalajara Jal]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Autónoma de Sinaloa Facultad de Enfermería ]]></institution>
<addr-line><![CDATA[Culiacán ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2024</year>
</pub-date>
<volume>29</volume>
<numero>3</numero>
<fpage>97</fpage>
<lpage>106</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2954-41222024000300097&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2954-41222024000300097&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2954-41222024000300097&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Antecedentes: El hematoma subdural crónico (HSDC) es una colección antigua de sangre y de sus productos de degradación en el espacio subdural, el tratamiento de elección en pacientes sintomáticos es el de craneotomía, aunque trae consigo complicaciones. Se ha incrementado la búsqueda de terapias alternativas, destacando los glucocorticoides, en especial de la dexametasona (DXM).  Objetivo: Describir la eficiencia, la eficacia y la seguridad del uso de DXM en pacientes mayores de 18 años con HSDC en comparación con el drenaje quirúrgico o un placebo.  Método: Se realizó una revisión sistemática de acuerdo con las pautas PRISMA 2020 y se llevaron a cabo búsquedas avanzadas en idiomas inglés y español en las bases de datos NEJM, PubMed y Embase a través de Cochrane Library, utilizando los descriptores y operadores booleanos "Dexamethasone" AND "Hematoma, Subdural, Chronic", y con el rango de años 2018-2023.  Resultados: Se encontraron 44 artículos, de los cuales, tras descartar duplicados y de aplicar criterios de inclusión y exclusión, solo se incluyeron cinco artículos.  Conclusión: La revisión muestra un impacto positivo en el riesgo de recurrencia con el uso de DXM en pacientes con HSDC; no obstante, los resultados no fueron concluyentes, ya que este impacto solo se demuestra en cuatro de las cinco publicaciones incluidas. Asimismo, está asociado a un mayor riesgo de complicaciones y mortalidad; además, no se demostró significancia en cuanto a resultados funcionales y días de hospitalización en comparación con los pacientes que recibieron cirugía primaria o placebo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Background: Chronic subdural hematoma (CSCH) is an old collection of blood and its degradation products in the subdural space, the treatment of choice in symptomatic patients is craniotomy, although it brings complications. The search for alternative therapies has increased, highlighting glucocorticoids, especially dexamethasone (DXM).  Objective: To describe the efficiency, efficacy, and safety of the use of DXM in patients older than 18 years with CSCH in comparison with surgical drainage or placebo group.  Method: Systematic review conducted according to PRISMA 2020 guidelines. Advanced searches were conducted in English and Spanish language, in the NEJM, PubMed and Embase databases through Cochrane Library using the descriptors and Boolean operators' "Dexamethasone" AND "Hematoma, Subdural, Chronic", and custom year range 2018-2023.  Results: 44 articles were found, of which, after discarding duplicates and applying the inclusion and exclusion criteria, only five articles were included.  Conclusion: The review shows a positive impact on the risk of recurrence with the use of DXM in patients with CSDH; however, no conclusive results were found since this impact was only demonstrated in four of the five publications included. Likewise, the use of DXM in patients with CSDH is associated with an increased risk of complications and mortality, and no significant difference was demonstrated in functional outcomes and days of hospitalization compared to those who received primary surgery or placebo.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Dexametasona]]></kwd>
<kwd lng="es"><![CDATA[Hematoma subdural crónico]]></kwd>
<kwd lng="es"><![CDATA[Revisión sistemática]]></kwd>
<kwd lng="en"><![CDATA[Dexamethasone]]></kwd>
<kwd lng="en"><![CDATA[Chronic subdural hematoma]]></kwd>
<kwd lng="en"><![CDATA[Systematic review]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yadav]]></surname>
<given-names><![CDATA[YR]]></given-names>
</name>
<name>
<surname><![CDATA[Parihar]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Namdev]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bajaj]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic subdural hematoma]]></article-title>
<source><![CDATA[Asian J Neurosurg]]></source>
<year>2016</year>
<volume>11</volume>
<page-range>330-42</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dammers]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Holl]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Kapiteijn]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Kompanje]]></surname>
<given-names><![CDATA[EJO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The first historical description of chronic subdural hematoma:a tale of inaccurate interpretation, inaccurate quoting and inaccurate requoting]]></article-title>
<source><![CDATA[J Hist Neurosci]]></source>
<year>2023</year>
<volume>32</volume>
<page-range>1-18</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kolias]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Chari]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Santarius]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Hutchinson]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic subdural haematoma:modern management and emerging therapies]]></article-title>
<source><![CDATA[Nat Rev Neurol]]></source>
<year>2014</year>
<volume>10</volume>
<page-range>570-8</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramachandran]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hegde]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic subdural hematomas —causes of morbidity and mortality]]></article-title>
<source><![CDATA[Surg Neurol]]></source>
<year>2007</year>
<volume>67</volume>
<page-range>367-72</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gascón Cerda]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar Pérez]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sandoval Bonilla]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Sikahall Meneses]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Torres Arreola]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía de práctica clínica]]></article-title>
<source><![CDATA[Diagnóstico y tratamiento del hematoma subdural crónico tarumático en pacientes mayores de 18 años de edad]]></source>
<year>2009</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Instituto Mexicano del Seguro Social]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viaroli]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Iaccarino]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Maduri]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas Daniel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Servadei]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Complications After Surgery for Chronic Subdural Hematomas]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Nanda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Complications in Neurosurgery]]></source>
<year>2019</year>
<page-range>274-9</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fountas]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kotlia]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Panagiotopoulos]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Fotakopoulos]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The outcome after surgical vs nonsurgical treatment of chronic subdural hematoma with dexamethasone]]></article-title>
<source><![CDATA[Interdisciplinary Neurosurgery]]></source>
<year>2019</year>
<volume>16</volume>
<page-range>70-4</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yao]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[You]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dexamethasone for chronic subdural haematoma:a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Acta Neurochir (Wien)]]></source>
<year>2017</year>
<volume>159</volume>
<page-range>2037-44</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Page]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Moher]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bossuyt]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Boutron]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Hoffmann]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Mulrow]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PRISMA 2020 explanation and elaboration:updated guidance and exemplars for reporting systematic reviews]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2021</year>
<volume>372</volume>
<page-range>n160</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cascaes da Silva]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Valdivia Arancibia]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[da Rosa Iop]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Barbosa Gutierres Filho]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[da Silva]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Escalas y listas de evaluación de la calidad de estudios científicos]]></article-title>
<source><![CDATA[Rev Cuba Inf Cienc Salud]]></source>
<year>2013</year>
<volume>24</volume>
<page-range>295-312</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Merino-Trujillo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Como escribir documentos científicos (Parte 3)]]></article-title>
<source><![CDATA[Artículo de revisión. Salud en Tabasco]]></source>
<year>2011</year>
<volume>17</volume>
<page-range>36-40</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Diener]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dex-CSDH trial:dexamethasone for chronic subdural hematoma]]></article-title>
<source><![CDATA[Arzneimitteltherapie]]></source>
<year>2021</year>
<volume>39</volume>
<page-range>84-5</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miah]]></surname>
<given-names><![CDATA[IP]]></given-names>
</name>
<name>
<surname><![CDATA[Holl]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Bruggink]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Peul]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
<name>
<surname><![CDATA[Tolman]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Walchenbach]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dexamethasone therapy versus surgery for chronic subdural haematoma, a clinical randomised controlled trial (DECSA-trial)]]></article-title>
<source><![CDATA[Eur J Neurol]]></source>
<year>2018</year>
<volume>25</volume>
<page-range>389</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Edlmann]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Giorgi-Coll]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Thelin]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
<name>
<surname><![CDATA[Hutchinson]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Carpenter]]></surname>
<given-names><![CDATA[KLH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dexamethasone reduces vascular endothelial growth factor in comparison to placebo in post-operative chronic subdural hematoma samples:a target for future drug therapy?]]></article-title>
<source><![CDATA[Front Neurol]]></source>
<year>2022</year>
<volume>13</volume>
<page-range>952308</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miah]]></surname>
<given-names><![CDATA[IP]]></given-names>
</name>
<name>
<surname><![CDATA[Blanter]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tank]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[van Zwet]]></surname>
<given-names><![CDATA[EW]]></given-names>
</name>
<name>
<surname><![CDATA[Rosendaal]]></surname>
<given-names><![CDATA[FR]]></given-names>
</name>
<name>
<surname><![CDATA[Peul]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Change in hematoma size after dexamethasone therapy in chronic subdural hematoma subtypes:a prospective study in symptomatic patients]]></article-title>
<source><![CDATA[J Neurotrauma]]></source>
<year>2023</year>
<volume>40</volume>
<page-range>228-39</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Holl]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Fakhry]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dirven]]></surname>
<given-names><![CDATA[CMF]]></given-names>
</name>
<name>
<surname><![CDATA[te Braake]]></surname>
<given-names><![CDATA[FAL]]></given-names>
</name>
<name>
<surname><![CDATA[Begashaw]]></surname>
<given-names><![CDATA[OK]]></given-names>
</name>
<name>
<surname><![CDATA[Moudrous]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Surgery after primary dexamethasone treatment for patients with chronic subdural hematoma —a retrospective study]]></article-title>
<source><![CDATA[World Neurosurg]]></source>
<year>2022</year>
<volume>162</volume>
<page-range>e358-68</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mebberson]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Colditz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Marshman]]></surname>
<given-names><![CDATA[LAG]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[PAW]]></given-names>
</name>
<name>
<surname><![CDATA[Mitchell]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Robertson]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prospective randomized placebo-controlled double-blind clinical study of adjuvant dexamethasone with surgery for chronic subdural haematoma with post-operative subdural drainage:interim analysis]]></article-title>
<source><![CDATA[J Clin Neurosci]]></source>
<year>2020</year>
<volume>71</volume>
<page-range>153-7</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hutchinson]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Edlmann]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bulters]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Zolnourian]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Holton]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Suttner]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trial of dexamethasone for chronic subdural hematoma]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2020</year>
<volume>383</volume>
<page-range>2616-27</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miah]]></surname>
<given-names><![CDATA[IP]]></given-names>
</name>
<name>
<surname><![CDATA[Holl]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Blaauw]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lingsma]]></surname>
<given-names><![CDATA[HF]]></given-names>
</name>
<name>
<surname><![CDATA[den Hertog]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Jacobs]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dexamethasone versus surgery for chronic subdural hematoma]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2023</year>
<volume>388</volume>
<page-range>2230-40</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miah]]></surname>
<given-names><![CDATA[IP]]></given-names>
</name>
<name>
<surname><![CDATA[Herklots]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Roks]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Peul]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
<name>
<surname><![CDATA[Walchenbach]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dammers]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dexamethasone therapy in symptomatic chronic subdural hematoma (DECSA–R):a retrospective evaluation of initial corticosteroid therapy versus primary surgery]]></article-title>
<source><![CDATA[J Neurotrauma]]></source>
<year>2020</year>
<volume>37</volume>
<page-range>366-72</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tariq]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bhatti]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adjunctive postoperative course of dexamethasone in chronic subdural hematoma:effect on surgical outcome]]></article-title>
<source><![CDATA[Pak J Med Sci]]></source>
<year>2021</year>
<volume>37</volume>
<page-range>1877</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
